| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3649509
Max Phase: Preclinical
Molecular Formula: C15H18ClN5O2
Molecular Weight: 335.80
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1cn(CCCN/C(=C\[N+](=O)[O-])Nc2ccc(Cl)cc2)cn1
Standard InChI: InChI=1S/C15H18ClN5O2/c1-12-9-20(11-18-12)8-2-7-17-15(10-21(22)23)19-14-5-3-13(16)4-6-14/h3-6,9-11,17,19H,2,7-8H2,1H3/b15-10+
Standard InChI Key: HYOMTYOMNXAQKB-XNTDXEJSSA-N
Associated Targets(Human)
Glutaminyl-peptide cyclotransferase-like protein 114 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 335.80 | Molecular Weight (Monoisotopic): 335.1149 | AlogP: 3.01 | #Rotatable Bonds: 8 |
| Polar Surface Area: 85.02 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.06 | CX Basic pKa: 6.39 | CX LogP: 2.15 | CX LogD: 2.12 |
| Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.44 | Np Likeness Score: -1.38 |
References
| 1. (2014) Inhibitors of glutaminyl cyclase, |
Source
Source(1):